Calcium channel blocker and angiotensin receptor blocker toxicity: A case report

Chloe Lahoud , Whitney Hovater , Angela Rosenberg , Gennifer Wahbah Makhoul , Gita Vatandoust , Mohamad Maruf
{"title":"Calcium channel blocker and angiotensin receptor blocker toxicity: A case report","authors":"Chloe Lahoud ,&nbsp;Whitney Hovater ,&nbsp;Angela Rosenberg ,&nbsp;Gennifer Wahbah Makhoul ,&nbsp;Gita Vatandoust ,&nbsp;Mohamad Maruf","doi":"10.1016/j.hmedic.2025.100181","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Calcium channel blockers and angiotensin II receptor blockers are commonly used medications. With an increased prevalence of cardiovascular (CV) disease worldwide, comes an increased use of CV medications. While relatively uncommon, CV medications toxicity can have significant mortality and morbidity, and necessitates complex management.</div></div><div><h3>Case</h3><div>A 63-year-old male with past medical history of hypertension, benign prostatic hyperplasia, myeloproliferative neoplasm, anxiety, and major depressive disorder presented to our emergency department (ED) for intentional polypharmacy overdose. The patient had severe hypotension and was found to have distributive shock due to acute amlodipine and losartan toxicity. The patient was managed with high dose insulin euglycemia therapy (HIET) with concomitant dextrose infusion and vasopressors in the intensive care unit. HIET is a treatment primarily used for severe toxicity caused by calcium channel blocker or beta-blocker overdoses, it works by improving myocardial contractility and increasing cardiac output through insulin's inotropic effects.</div></div><div><h3>Conclusion</h3><div>Combined CCB and ARB toxicity can lead to very severe hypotension and hemodynamic instability. Several treatment options are available, with the first-line options being HIET, vasopressors, and calcium.</div></div>","PeriodicalId":100908,"journal":{"name":"Medical Reports","volume":"10 ","pages":"Article 100181"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949918625000269","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Calcium channel blockers and angiotensin II receptor blockers are commonly used medications. With an increased prevalence of cardiovascular (CV) disease worldwide, comes an increased use of CV medications. While relatively uncommon, CV medications toxicity can have significant mortality and morbidity, and necessitates complex management.

Case

A 63-year-old male with past medical history of hypertension, benign prostatic hyperplasia, myeloproliferative neoplasm, anxiety, and major depressive disorder presented to our emergency department (ED) for intentional polypharmacy overdose. The patient had severe hypotension and was found to have distributive shock due to acute amlodipine and losartan toxicity. The patient was managed with high dose insulin euglycemia therapy (HIET) with concomitant dextrose infusion and vasopressors in the intensive care unit. HIET is a treatment primarily used for severe toxicity caused by calcium channel blocker or beta-blocker overdoses, it works by improving myocardial contractility and increasing cardiac output through insulin's inotropic effects.

Conclusion

Combined CCB and ARB toxicity can lead to very severe hypotension and hemodynamic instability. Several treatment options are available, with the first-line options being HIET, vasopressors, and calcium.
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信